Zoetis, a leading animal health company, opened for trading today on the New York Stock Exchange (NYSE) under the ticker symbol “ZTS” after its initial public offering. Barclays is the Designated Market Maker (DMM) for the company’s stock. CEO Juan Ramón Alaix, joined by members of the Zoetis team, celebrated the company’s first day of trading by visiting the NYSE trading floor for the stock opening and by ringing The Opening Bell.
Zoetis Chief Executive Officer Juan Ramon Alaix, joined by members of the Zoetis team, rings the NYSE Opening Bell to celebrate the company's IPO and first day of trading on the NYSE. (Source: NYSE Euronext Photo)"We welcome Zoetis to our growing community of listed companies,” said Scott Cutler, Executive Vice President, Head of Global Listings, NYSE Euronext. “As the largest standalone company in animal health, Zoetis supports veterinarians and livestock producers around the world with innovative medicines and vaccines that help them raise and care for animals. We congratulate Zoetis as they embark upon this new chapter and look forward to a long-standing partnership with the company and its shareholders.” For more information on NYSE Euronext’s Listings business and to learn about trends in the IPO market, please visit the NYSE Euronext IPO Center. About Zoetis (NYSE: ZTS) Zoetis (zō-EH-tis) is the leading animal health company, dedicated to supporting its customers and their businesses. Building on a 60-year history as the animal health business of Pfizer, Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, with a focus on both farm and companion animals. The company generated annual revenue of $4.2 billion in fiscal 2011. Zoetis has more than 9,500 employees and a local presence in approximately 70 countries, including 29 manufacturing facilities in 11 countries. Its products serve veterinarians, livestock producers and people who raise and care for farm and companion animals in 120 countries. (Source: Zoetis) About NYSE Euronext NYSE Euronext (NYX) is a leading global operator of financial markets and provider of innovative trading technologies. The company's exchanges in Europe and the United States trade equities, futures, options, fixed-income and exchange-traded products. With approximately 8,000 listed issues (excluding European Structured Products), NYSE Euronext's equities markets - the New York Stock Exchange, NYSE Euronext, NYSE MKT, NYSE Alternext and NYSE Arca - represent one-third of the world’s equities trading, the most liquidity of any global exchange group. NYSE Euronext also operates NYSE Liffe, one of the leading European derivatives businesses and the world's second-largest derivatives business by value of trading. The company offers comprehensive commercial technology, connectivity and market data products and services through NYSE Technologies. NYSE Euronext is in the S&P 500 index. For more information, please visit: http://www.nyx.com.